Request for Letters of Intent
The Perry and Ruby Stevens Parkinson’s Disease Center of Excellence, in collaboration with the Center for Innovative Drug Discovery(CIDD) is soliciting letters of intent (LOIs) that present pilot project concepts focusing on discovery and development of novel drugs for Parkinson’s disease (PD). The primary goal of this program is to accelerate PD research at UT Health San Antonio (UTHSA) by supporting innovative projects aimed at slowing the progression of PD and/or improving functional status for those living with progressive PD. For details, view the Request for Letters of Intent.
All applicants must submit a Letter of Intent by August 24, 2026.
Full applications will be due soon after consultations with CIDD scientists.
- SurveyMonkey Apply — 2026-2027 Parkinson’s Drug Development
- Attach forms in single document:
- Biographical Sketch for PI (maximum 5 pages; for NIH template, format, and sample see Biographical Sketch Common Form)
- Biographical Sketch for Key Personnel (maximum 5 pages each)
- Budget
- Research plan (maximum 2 pages)
- Identification of PD-relevant disease pathway and drug target
- Background and rationale
- Preliminary data, if available
- Drug development strategy
- Literature citations (optional; maximum 1 page – use continuation page)
- Appendices are not allowed
- A UTHSA Certificate of Proposal (COP) is not required at the time of submission
Important Dates
| Letter of Intent Due | August 24, 2026 |
| Consultations with CIDD | September 2026 |
| Full Proposal Due | October 28, 2026 |
| Peer Review Selection | November 2026 |
For questions, please e-mail Cindy Castilleja (castillejac@uthscsa.edu)